Attitudes and behaviors of psychiatry residents toward pharmaceutical representatives before and after an educational intervention

Academic Psychiatry

Volumn 29, Issue 1, 2005, Pages 33-39

  Randall, Melinda L ^a,c   Rosenbaum, Julie R ^b   Rohrbaugh, Robert M ^a   Rosenheck, Robert A ^a  

^a VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^b YALE UNIVERSITY   (United States)

^c VACHS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONTROLLED STUDY; EDUCATION PROGRAM; HEALTH PERSONNEL ATTITUDE; HEALTH SURVEY; HUMAN; HUMAN EXPERIMENT; PRESCRIPTION; RESIDENCY EDUCATION; RESIDENT; UNIVERSITY HOSPITAL;

ADULT; ATTITUDE OF HEALTH PERSONNEL; DRUG INDUSTRY; EDUCATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERNSHIP AND RESIDENCY; MALE; PSYCHIATRY; QUESTIONNAIRES; SOCIAL BEHAVIOR;

EID: 14544278371     PISSN: 10429670     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ap.29.1.33     Document Type: Article

References (19)

1. Wazana A: Physicians and the pharmaceutical industry: is a gift ever just a gift? [see comments]. JAMA 2000; 283:373-380
2. Smith MC: Drug product advertising and prescribing: a review of the evidence. Am J Hosp Pharm 1977; 34:1208-1224
3. Lexchin J: Interactions between physicians and the pharmaceutical industry: what does the literature say? Can Med Assoc J 1993; 149:1401-1407
4. Hemminki E: Review of literature on the factors affecting drug prescribing. Soc Sci Med 1975; 9:111-116
5. Schwartz TL, Kuhles DJ 2nd, Wade M, Masand PS: Newly admitted psychiatric patient prescriptions and pharmaceutical sales visits. Ann Clin Psychiatry 2001; 13:159-162
6. AMA: Current opinions. AMA policy compendium 1999
7. America PRaMo: PhRMA Code on Interactions with Healthcare Professionals, 2002, pp 1-9
8. General OoI: Compliance Program Guidance for Pharmaceutical Manufacturers, 2003, pp 13-38
9. Hodges B: Interactions with the pharmaceutical industry: experiences and attitudes of psychiatry residents, interns and clerks. Can Med Assoc J 1995; 153:553-559
10. McKinney WP, Schiedermayer DL, Lurie N, Simpson DE, Goodman JL, Rich EC: Attitudes of internal medicine faculty and residents toward professional interaction with pharmaceutical sales representatives. JAMA 1990; 264:1693-1697
11. Sergeant MD, Hodgetts PG, Godwin M, Walker DM, McHenry P: Interactions with the pharmaceutical industry: a survey of family medicine residents in Ontario. Can Med Assoc J 1996; 155:1243-1248
12. Lichstein PR, Turner RC, O'Brien K: Impact of pharmaceutical company representatives on internal medicine residency programs: a survey of residency program directors. Arch Intern Med 1992; 152:1009-1013
13. Brotzman GL, Mark DH: The effect on resident attitudes of regulatory policies regarding pharmaceutical representative activities. J Gen Intern Med 1993; 8:130-134
14. Shaughnessy AF, Slawson DC, Bennett JH: Teaching information mastery: evaluating information provided by pharmaceutical representatives. Fam Med 1995; 27:581-585
15. Hopper JA, Speece MW, Musial JL: Effects of an educational intervention on residents' knowledge and attitudes toward interactions with pharmaceutical representatives. J Gen Intern Med 1997; 12:639-642
16. Waud DR: Pharmaceutical promotions - a free lunch? N Engl J Med 1992; 327:351-353
17. Howard SM: Gifts to physicians from the pharmaceutical industry [comment]. JAMA 2000; 283:2655-2666; discussion 2657-2658
18. Shaughnessy AF, Slawson DC, Bennett JH: Separating the wheat from the chaff: identifying fallacies in pharmaceutical promotion. J Gen Intern Med 1994; 9:563-568
19. Steinman MA, Shlipak MG, McPhee SJ: Of principles and pens: attitudes and practices of medicine housestaff toward pharmaceutical industry promotions. Am J Med 2001; 110: 551-557